InvestorsHub Logo
Followers 3
Posts 573
Boards Moderated 0
Alias Born 08/27/2020

Re: None

Monday, 01/08/2024 10:43:19 AM

Monday, January 08, 2024 10:43:19 AM

Post# of 44209
Dr. Heah has led multiple successful global ophthalmic innovation, regulatory submissions and commercialization of products including Ozurdex®, EYLEA®, Rhopressa® & Rocklatan.® While at Bayer, she launched EYLEA® successfully into its eventual status as a blockbuster drug.